Today: 9 June 2026
Lam Research (LRCX) stock slips despite fresh Bernstein target as jobs, CPI loom
9 February 2026
1 min read

Lam Research (LRCX) stock slips despite fresh Bernstein target as jobs, CPI loom

New York, February 9, 2026, 11:16 EST — Regular session

  • Lam Research slipped roughly 0.6% in late morning trading, bottoming out at $223.61.
  • Bernstein upped its price target to $285, sticking with an Outperform rating, MT Newswires said.
  • This week, traders have their eyes on the postponed U.S. payrolls data and January CPI, scanning both for signs on where rates might be heading.

Lam Research slipped roughly 0.6%, sitting at $229.73 as of 11:16 a.m. ET. The stock had touched a session low of $223.61 earlier. For the last 52 weeks, the semiconductor equipment maker’s shares have ranged from $71.33 up to $243.99.

Shares barely budged, despite Bernstein bumping its Lam price target up to $285 from $275 and sticking with an Outperform call, according to MT Newswires. The fresh target points to about 24% upside from where the stock closed Monday. Still, chip stocks faced a rough session.

The backdrop takes center stage now. U.S. stocks started the session mixed, with investors eyeing a slate of economic data that could jolt interest-rate expectations—Wednesday’s January nonfarm payrolls, then the consumer price index coming Friday. “Investors are less comfortable with the amount of spending,” B Riley Wealth’s Art Hogan said, pointing specifically to the hefty capital spending from the tech giants, which has turned into a sticking point for the market. Reuters

The debate’s left chip stocks swinging back and forth. In a Reuters “Morning Bid” note, chipmakers led Friday’s bounce—Nvidia, AMD, and Broadcom all surged above 7%. But there’s still unease over the high price tags for hyperscalers. Amazon dropped 5.6% after revealing a steep capital spending hike for 2026. Reuters

Lam occupies a key spot in the spending loop, supplying deposition and etch equipment—critical machines for layering features onto silicon wafers—to chipmakers scaling up leading-edge logic and advanced memory.

Investors are zeroed in on order momentum right now, watching closely to see if customers stick with their factory expansion plans while the market absorbs the price tag of the AI buildout. Toolmakers can swing from looking sturdy one week to showing their cyclical stripes the next.

There’s a catch: should chipmakers pull back on capex, push off new fabs, or clamp down on spending after this quarter’s guidance, equipment demand could fade fast. And stocks usually adjust before the order books reflect it.

Thursday brings the next test for the sector as Applied Materials prepares to release its fiscal first-quarter numbers after the bell, followed by a 4:30 p.m. ET conference call. Investors will be watching closely for any change in its wafer-fab equipment spending outlook—a move that could sway sentiment for Lam and the rest of the group through week’s end.

Stock Market Today

  • Semiconductor Stock Poised to Surpass Micron Technology by 2028
    June 9, 2026, 10:18 AM EDT. Micron Technology has surged nearly 800% recently, driven by high demand and pricing power in memory chips, pushing its market cap past $1 trillion. However, analysts predict supply constraints easing by 2028 could cause earnings to peak and decline, potentially halving share value to around $517.50. Meanwhile, a major semiconductor competitor valued around $650 billion is expanding production, potentially surpassing Micron's value by 2028. The industry faces cyclical dynamics as new manufacturing capacity comes online globally, impacting pricing and earnings. Investors are watching these shifts closely for long-term positioning amid evolving chip supply and demand.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Uber’s new ride-booking kiosks and Adyen expansion spotlight fintech’s 2026 embedded-finance push
Previous Story

Uber’s new ride-booking kiosks and Adyen expansion spotlight fintech’s 2026 embedded-finance push

Silver price jumps again as dollar slips — here’s what traders watch next
Next Story

Silver price jumps again as dollar slips — here’s what traders watch next

Go toTop